Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARMEN: Tacrolimus-Rituximab vs Steroids-Cyclophosphamide in Primary Membranous Nephropathy
NCT01955187Phase 3Completed
- Sponsor
- Hospital Universitario 12 de Octubre
- Start
- Jan 2014
- Primary completion
- Jun 2019
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus + Wuzhi capsule and rituximab in membranous nephropathy (MN), sponsored by Hospital Universitario 12 de Octubre. Started Jan 2014; status: completed.
02
Drugs
tacrolimus + Wuzhi capsulerituximab
03
Conditions
membranous nephropathy (MN)
Beyond the preview
Go deeper on NCT01955187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955187.